Angiotensin III: A central regulator of vasopressin release and blood pressure

Trends in Endocrinology and Metabolism

Volumn 12, Issue 4, 2001, Pages 157-162

  Reaux, Annabelle ^a   Fournie Zaluski, Marie Claude ^b   Llorens Cortes, Catherine ^a  

^a Centre de Recherche Interdisciplinaire en Biologie   (France)

^b INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN II; ANGIOTENSIN III; ARGIPRESSIN; VASOPRESSIN DERIVATIVE;

ANIMAL; BLOOD PRESSURE; BRAIN; DRUG EFFECT; HUMAN; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; PHYSIOLOGY; REVIEW; SECRETION;

ANGIOTENSIN II; ANGIOTENSIN III; ANIMALS; ARGININE VASOPRESSIN; BLOOD PRESSURE; BRAIN; HUMANS; INJECTIONS, INTRAVENTRICULAR; VASOPRESSINS;

EID: 0035347330     PISSN: 10432760     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1043-2760(01)00381-2     Document Type: Review

References (64)

1. Oparil, S. et al. (1995) The role of the central nervous system in hypertension. In Hypertension: Pathophysiology, Diagnosis and Management (Laragh, J.H. and Brenner, B.M., eds), pp. 713-740, Raven Press
2. Averill, D.B. et al. (1996) Role of area postrema in transgene hypertension. Hypertension 27, 591-597
3. Davisson, R.L. et al. (1998) The brain renin-angiotensin system contributes to the hypertension in mice containing both the human renin and human angiotensinogen transgenes. Circ. Res. 83, 1047-1058
4. Allen, A.M. et al. (1992) Localization of angiotensin receptor binding sites in the rat brain. In Handbook of Chemical Neuroanatomy: Neuropeptide Receptors in the CNS (Vol. 11) (Björklund, A. et al., eds), pp. 1-37, Elsevier
5. Saavedra, J.M. (1992) Brain and pituitary angiotensin. Endocr. Rev. 13, 329-380
6. Lenkei, Z. et al. (1997) Expression of angiotensin type-1 (AT1) and type-2 (AT2) receptor mRN As in the adult rat brain: a functional neuroanatomical review. Front. Neuroendocrinol. 18, 383-439
7. Phillips, M.I. and Sumners, C. (1998) Angiotensin II in central nervous system physiology. Regul. Pept. 78, 1-11
8. Murphy, T.J. et al. (1991) Isolation of a cDNA encoding the vascular type-1 angiotensin II receptor. Nature 351, 233-236
9. Kambayashi, Y. et al. (1993) Molecular cloning of a novel angiotensin II receptor isoform involved in phosphotyrosine phosphatase inhibition. J. Biol. Chem. 268, 24543-24546
10. Mukoyama, M. et al. (1993) Expression cloning of type 2 angiotensin II receptor reveals a unique class of seven-transmembrane receptors. J. Biol. Chem. 268, 24539-24542
11. Phillips, M.I. (1987) Functions of angiotensin in the central nervous system. Annu. Rev. Physiol. 49, 413-435
12. Wright, J.W. and Harding, J.W. (1997) Important role for angiotensin III and IV in the brain renin-angiotensin system. Brain Res. Rev. 25, 96-124
13. Malfroy B. et al. (1989) Molecular cloning and amino acid sequence of rat kidney aminopeptidase M: a member of a super family of zinc-metallohydrolases. Biochem. Biophys. Res. Commun. 161, 236-241
14. Wu, Q. et al. (1990) Molecular cloning of the murine BP-1/6C3 antigen: a member of the zinc-dependent metallopeptidase family. Proc. Natl. Acad. Sci. U. S. A. 87, 993-997
15. Vazeux, G. et al. (1996) Identification of glutamate residues essential for catalytic activity and zinc coordination in aminopeptidase A. J. Biol. Chem. 271, 9069-9074
16. Wilk, S. and Healy D.P. (1993) Glutamyl aminopeptidase (aminopeptidase A), the BP-1/6C3 antigen. Adv. Neuroimmunol. 3, 195-207
17. Palmieri, F.E. et al. (1989) Metabolism of vasoactive peptides by vascular endothelium and smooth muscle aminopeptidase M. Biochem. Pharmacol. 38, 173-180
18. Hersh, L.B. et al. (1987) Immunohistochemical localization of aminopeptidase M in rat brain and periphery: relationship of enzyme localization and enkephalin metabolism. Peptides 8, 523-532
19. Healy D.P. and Wilk, S. (1993) Localization of immunoreactive glutamyl aminopeptidase in rat brain. II. Distribution and correlation with angiotensin II. Brain Res. 606, 295-303
20. Troyanovskaya, M. et al. (2000) Aminopeptidase-A. I. cDNA cloning and expression and localization in rat tissues. Am. J. Physiol. 278, R413-R424
21. Zini, S. et al. (1997) Aminopeptidase A: distribution in rat brain nuclei and increased activity in spontaneously hypertensive rats. Neuroscience 78, 1187-1193
22. Lind, R.W. and Ganten, D. (1990) Angiotensin. In Handbook of Chemical Neuroanatomy (Vol. 9, Part II) (Björklund, A. et al., eds), pp. 165-286, Elsevier
23. 125I]angiotensins in rat. J. Neurochem. 46, 1292-1297
24. Abhold, R.H. et al. (1987) Binding, degradation and presser activity of angiotensins II and III after aminopeptidase inhibition with amastatin and bestatin. J. Pharmacol. Exp. Ther. 242, 957-962
25. 125I] angiotensins in the cerebroventricles of the rat. Brain Res. 448, 369-372
26. Harding, J.W. and Felix, D. (1987) The effects of aminopeptidase inhibitors amastatin and bestatin on angiotensin-evoked neuronal activity in rat brain. Brain Res. 424, 299-304
27. Checler, F. (1993) Neuropeptide-degrading peptidases. In Methods in Neurotransmitter and Neuropeptide Research (Parvez, S.H. et al., eds), pp. 375-418, Elsevier
28. Tieku, S. and Hooper, N.M. (1992) Inhibition of aminopeptidases N, A and W. A re-evaluation of the actions of bestatin and inhibitors of angiotensin converting enzyme. Biochem. Pharmacol. 44, 1725-1730
29. Chauvel, E.N. et al. (1994) Differential inhibition of aminopeptidase A and aminopeptidase N by new beta-amino thiols. J. Med. Chem. 37, 2950-2957
30. Fournie-Zaluski, M.C. et al. (1992) Potent and systemically active aminopeptidase N inhibitors designed from active-site investigation. J. Med. Chem. 35, 1259-1266
31. Reaux, A. et al. (1999) PC 18, a specific aminopeptidase N inhibitor, induces vasopressin release by increasing the half-life of brain angiotensin III. Neuroendocrinology 69, 370-376
32. Hopsu, V.K. et al. (1966) Characterization of aminopeptidase B: substrate specificity and affector studies. Arch. Biochem. Biophys. 114, 567-575
33. Cadel, S. et al. (1995) Aminopeptidase-B in the rat testes: isolation, functional properties and cellular localization in the seminiferous tubules. Mol. Cell. Endocrinol. 110, 149-160
34. Zini, S. et al. (1996) Identification of metabolic pathways of brain angiotensin II and III using specific aminopeptidase inhibitors: predominant role of angiotensin III in the control of vasopressin release. Proc. Natl. Acad. Sci. U. S. A. 93, 11968-11973
35. Bargmann, W. and Scharrer, E. (1951) The site of origin of the hormones of the posterior pituitary. Am. Sci. 39, 255-259
36. Renaud, L.P. and Bourque, C.W. (1991) Neurophysiology and neuropharmacology of hypothalamic magnocellular neurons secreting vasopressin and oxytocin. Prog. Neurobiol. 36, 131-169
37. Yamaguchi, K. et al. (1979) A comparison between the effects of angiotensin II and angiotensin III injected into the third cerebral ventricle on vasopressin secretion in conscious rats (author's translation). Nippon Naibunpi Gakkai Zasshi 55, 1286-1295
38. Hohle, S. et al. (1995) Angiotensin AT1 receptor-mediated vasopressin release and drinking are potentiated by an AT2 receptor antagonist. Eur. J. Pharmacol. 275, 277-282
39. Veltmar, A. et al. (1992) Involvement of adrenergic and angiotensinergic receptors in the paraventricular nucleus in the angiotensin II-induced vasopressin release. J. Pharmacol. Exp. Ther. 263, 1253-1260
40. Hogarty D.C. et al. (1992) The role of angiotensin, AT1 and AT2 receptors in the pressor, drinking and vasopressin responses to central angiotensin. Brain Res. 586, 289-294
41. Meng, H. et al. (1994) Antisense oligonucleotide to AT1 receptor mRNA inhibits central angiotensin induced thirst and vasopressin. Regul. Pept. 54, 543-551
42. Zini, S. et al. (1998) Inhibition of vasopressinergic neurons by central injection of a specific aminopeptidase A inhibitor. Neuro Report 9, 825-828
43. Potts, P.D. et al. (2000) Does angiotensin II have a significant tonic action on cardiovascular neurons in the rostral and caudal VLM? Am. J. Physiol. Regul. Integr. Comp. Physiol. 279, R1392-R1402
44. Ito, S. and Sved, A.F. (2000) Pharmacological profile of depressor response elicited by sarthran in rat ventrolateral medulla. Am. J. Physiol. Heart Circ. Physiol. 279, H2961-H2966
45. Yamaguchi, K. et al. (1980) Effects of intraventricular injection of Sar1-Ala8-angiotensin II on plasma vasopressin level increased by angiotensin II and by water deprivation in conscious rats. Acta Endocrinol. 93, 407-412
46. Keil, L.C. et al. (1983) Vasopressinrelease induced by water deprivation: effects of centrally administered saralasin. Neuroendocrinology 37, 401-405
47. Lee, W.J. et al. (1995) Central Ang II-receptor antagonists impair cardiovascular and vasopressin response to hemorrhage in rats. Am. J. Physiol. 268, R1500-R1506
48. Yang, C.R. et al. (1992) Angiotensin II receptor activation depolarizes rat supraoptic neurons in vitro. Am. J. Physiol. 263, R1333-R1338
49. Wright, J.W. et al. (1985) Presser action and dipsogenicity induced by angiotensin II and III in rats. Am. J. Physiol. 249, R514-R521
50. Wright, J.W. et al. (1989) Structure-function analyses of brain angiotensin control of pressor action in rats. Am. J. Physiol. 257, R1551-R1557
51. Felix, D. and Schlegel, W. (1978) Angiotensin receptive neurones in the subfornical organ. Structure-activity relations. Brain Res. 149, 107-116
52. Harding, J.W. and Felix, D. (1987) Angiotensin-sensitive neurons in the rat paraventricular nucleus: relative potencies of angiotensin II and angiotensin III. Brain Res. 410, 130-134
53. Harding, J.W. et al. (1992) Release of angiotensins in paraventricular nucleus of rat in response to physiological and chemical stimuli. Am. J. Physiol. 262, F17-F23
54. Wright, J.W. et al. (1990) Intracerebroventricularly infused [D-Arg1]angiotensin III, is superior to [D-Asp1]angiotensin II, as a pressor agent in rats. Brain Res. 514, 5-10
55. Batt, C.M. et al. (1988) Pressor responses to amastatin, bestatin and Plummer's inhibitors are suppressed by pretreatment with the angiotensin receptor antagonist sarthran. Brain Res. Bull. 21, 731-735
56. Reaux, A. et al. (1999) Aminopeptidase A inhibitors as potential central antihypertensive agents. Proc. Natl. Acad. Sci. U. S. A. 96, 13415-13420
57. Wright, J.W. et al. (1990) Aminopeptidase-induced elevation and reduction in blood pressure in the spontaneously hypertensive rat. J. Hypertens. 8, 969-974
58. Wright, J.W. et al. (1989) Leucine aminopeptidase M-induced reductions in blood pressure in spontaneously hypertensive rats. Hypertension 13, 910-915
59. Song, L. et al. (1997) Aminopeptidase Aantiserum inhibits intracerebroventricular angiotensin II-induced dipsogenic and pressor responses. Brain Res. 744, 1-6
60. Waksman, G. et al. (1985) In vitro and in vivo effects of kelatorphan on enkephalin metabolism in rodent brain. Eur. J. Pharmacol. 117, 233-243
61. Llorens-Cortes, C. et al. (1986) Steady-state level and turnover rate of the tripeptide Tyr-Gly-Gly as indexes of striatal enkephalin release in vivo and their reduction during pentobarbital anesthesia. Proc. Natl. Acad. Sci. U. S. A. 83, 6226-6230
62. Ferrario, C.M. et al. (1997) Counterregulatory actions of angiotensin-(1-7). Hypertension 30, 535-541
63. Chansel, D. et al. (1998) Characterization of angiotensin IV-degrading enzymes and receptors on rat mesangial cells. Am. J. Physiol. 275, F535-F542
64. Itaya, Y. et al. (1986) Central renin-angiotensin system and the pathogenesis of DOCA-salt hypertension in rats. Am. J. Physiol. 251, H261-H268